Cargando…

ILC3s protect intestinal stem cells from chemotherapy

Detalles Bibliográficos
Autor principal:	Eberl, Gérard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2015
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612088/ https://www.ncbi.nlm.nih.gov/pubmed/26482141 http://dx.doi.org/10.1084/jem.21211insight3

Ejemplares similares

Epithelial IKKα licenses ILC3s to defend the intestinal barrier
por: Eftychi, Christina, et al.
Publicado: (2015)

ILC2s chew the fat
por: Ricardo-Gonzalez, Roberto R., et al.
Publicado: (2019)

Switch hitter: Bcl11b in T cells and ILC2s
por: Harly, Christelle, et al.
Publicado: (2019)

Bcl11b drives the birth of ILC2 innate lymphocytes
por: Zhong, Chao, et al.
Publicado: (2015)

Mitochondria deliver a gut check to intestinal stem cells
por: Short, Ben
Publicado: (2017)

ILC2s are the predominant source of intestinal ILC-derived IL-10
por: Bando, Jennifer K., et al.
Publicado: (2019)

Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset
por: Abidi, Ahmed, et al.
Publicado: (2020)

ILC precursors differentiate into metabolically distinct ILC1-like cells during Mycobacterium tuberculosis infection
por: Corral, Dan, et al.
Publicado: (2022)

Inflammation triggers ILC3 patrolling of the intestinal barrier
por: Jarade, Angélique, et al.
Publicado: (2022)

Intestinal-derived ILCs migrating in lymph increase IFNγ production in response to Salmonella Typhimurium infection
por: Kästele, Verena, et al.
Publicado: (2021)

Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion
por: Muraoka, Wayne T., et al.
Publicado: (2020)

Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
por: Stojanović, Ivana, et al.
Publicado: (2021)

FLT3 dancing on the stem cell
por: Levis, Mark
Publicado: (2017)

Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology
por: Sunaga, Shogo, et al.
Publicado: (2022)

Protecting normal cells from the cytotoxicity of chemotherapy
por: Cheok, Chit Fang
Publicado: (2012)

Transcription factor-driven regulation of ILC1 and ILC3
por: Schroeder, Jan-Hendrik, et al.
Publicado: (2022)

Antigen recognition by human γδ T cells: one step closer to knowing
por: Eberl, Matthias
Publicado: (2020)

ILC3s control splenic cDC homeostasis via lymphotoxin signaling
por: Vanderkerken, Matthias, et al.
Publicado: (2021)

ILC1 drive intestinal epithelial and matrix remodelling
por: Jowett, Geraldine M., et al.
Publicado: (2021)

FXR mediates ILC-intrinsic responses to intestinal inflammation
por: Fu, Ting, et al.
Publicado: (2022)

Observation on the efficacy of sublingual immunotherapy with dust mite allergen for perennial allergic rhinitis and the mechanism of action on ILCs with ILC1s and ILC2s and ILC3s
por: Tang, Guangjun, et al.
Publicado: (2022)

Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation
por: Li, Jingyu, et al.
Publicado: (2019)

Unique and redundant functions of NKp46(+) ILC3s in models of intestinal inflammation
por: Song, Christina, et al.
Publicado: (2015)

ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation
por: Pearson, Claire, et al.
Publicado: (2016)

Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier
por: Talbot, Jhimmy, et al.
Publicado: (2020)

Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
por: Zhang, Yunshu, et al.
Publicado: (2023)

‘ILC-poiesis’: generating tissue ILCs from naïve precursors
por: Di Santo, James P., et al.
Publicado: (2017)

Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn’s disease patients
por: Li, Jian, et al.
Publicado: (2016)

ILC
por: Stanitzki, Marcel
Publicado: (2018)

Critical role for CX(3)CR1(+) mononuclear phagocytes in intestinal homeostasis
por: Trinchieri, Giorgio
Publicado: (2014)

ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
por: Bouchery, Tiffany, et al.
Publicado: (2019)

Comment on “ILC1 drive intestinal epithelial and matrix remodeling”
por: Hariss, Fatima, et al.
Publicado: (2021)

Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity
por: Qi, Xinyi, et al.
Publicado: (2020)

ILC3s restrict the dissemination of intestinal bacteria to safeguard liver regeneration after surgery
por: Jakob, Manuel O., et al.
Publicado: (2023)

Stem cell slowdown
por: Leslie, Mitch
Publicado: (2008)

Sympathy for stem cells
por: Wells, William A.
Publicado: (2006)

Dihydromyricetin Protects Intestinal Barrier Integrity by Promoting IL-22 Expression in ILC3s through the AMPK/SIRT3/STAT3 Signaling Pathway
por: Zhou, Jie, et al.
Publicado: (2023)

The IL-33-ILC2 pathway protects from amebic colitis
por: Uddin, Md Jashim, et al.
Publicado: (2021)

ILC1s and ILC3s Exhibit Inflammatory Phenotype in Periodontal Ligament of Periodontitis Patients
por: Li, Changyi, et al.
Publicado: (2021)

Wnt + BMP = stem cell
por: LeBrasseur, Nicole
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_msdpkjjp72i411eqmakcpgohio